Literature DB >> 8033502

Loop-sheet polymerization: the structural basis of Z alpha 1-antitrypsin accumulation in the liver.

D A Lomas1.   

Abstract

1. The Z deficiency variant of alpha 1-antitrypsin predisposes the homozygote to early-onset panlobular emphysema and results in the accumulation of antitrypsin within the hepatocyte, which leads to hepatocellular damage and cirrhosis. The mechanism of this accumulation has been shown to be due to the Z mutation (Glu-342-->Lys) perturbing the structure of the protein, allowing a unique interaction between the reactive-centre loop of one molecule and the A sheet of a second. This loop-sheet polymerization occurs spontaneously at 37 degrees C in purified plasma Z but not M antitrypsin. The rate of polymerization is greatly accelerated at 41 degrees C and is blocked by the insertion of a specific peptide into the A sheet of the antitrypsin molecule. Electron microscopy and circular dichroic spectral analysis confirm that the Z antitrypsin polymers formed in vitro have structural identity with those isolated from the liver of a Z homozygote. 2. That loop-sheet polymerization is a more general phenomenon was shown by the examination of a second deficiency variant, antitrypsin Siiyama (Ser-53-->Phe), which is also associated with liver inclusions. Electron microscopy confirmed that isolated antitrypsin Siiyama from the plasma of a homozygote was present as long chains of polymers identical with those of Z antitrypsin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033502     DOI: 10.1042/cs0860489

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

Review 1.  Gene therapy for alpha-1 antitrypsin deficiency.

Authors:  Terence R Flotte; Christian Mueller
Journal:  Hum Mol Genet       Date:  2011-04-16       Impact factor: 6.150

Review 2.  Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.

Authors:  Alisha M Gruntman; Terence R Flotte
Journal:  Hum Gene Ther Methods       Date:  2015-06       Impact factor: 2.396

3.  Impact of HIV infection on α1-antitrypsin in the lung.

Authors:  Sarah E Stephenson; Carole L Wilson; Kristina Crothers; Engi F Attia; Cherry Wongtrakool; Irina Petrache; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

4.  Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency.

Authors:  N Novoradovskaya; J Lee; Z X Yu; V J Ferrans; M Brantly
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

5.  Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels.

Authors:  Kazuya Setoh; Chikashi Terao; Shigeo Muro; Takahisa Kawaguchi; Yasuharu Tabara; Meiko Takahashi; Takeo Nakayama; Shinji Kosugi; Akihiro Sekine; Ryo Yamada; Michiaki Mishima; Fumihiko Matsuda
Journal:  Nat Commun       Date:  2015-07-15       Impact factor: 14.919

6.  5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.

Authors:  Christian Mueller; Gwladys Gernoux; Alisha M Gruntman; Florie Borel; Emer P Reeves; Roberto Calcedo; Farshid N Rouhani; Anthony Yachnis; Margaret Humphries; Martha Campbell-Thompson; Louis Messina; Jeffrey D Chulay; Bruce Trapnell; James M Wilson; Noel G McElvaney; Terence R Flotte
Journal:  Mol Ther       Date:  2017-04-10       Impact factor: 11.454

7.  AFM Imaging Reveals Topographic Diversity of Wild Type and Z Variant Polymers of Human α1-Proteinase Inhibitor.

Authors:  Maria Gaczynska; Przemyslaw Karpowicz; Christine E Stuart; Malgorzata G Norton; Jeffrey H Teckman; Ewa Marszal; Pawel A Osmulski
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.